Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China
· Delayed Price · Currency is CNY 10.09
+0.43 (4.45%)
Apr 29, 2026, 3:04 PM CST
SHE:300439 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 3,713 | 3,786 | 4,012 | 4,447 | 4,481 | 8,162 | Upgrade
|
| Market Cap Growth | -17.99% | -5.65% | -9.77% | -0.77% | -45.10% | 30.24% | Upgrade
|
| Enterprise Value | 2,842 | 2,927 | 3,217 | 3,671 | 4,153 | 8,093 | Upgrade
|
| Last Close Price | 9.66 | 9.85 | 10.31 | 11.28 | 11.27 | 20.36 | Upgrade
|
| PE Ratio | 60.38 | 59.90 | 15.55 | 17.33 | 22.57 | 45.47 | Upgrade
|
| Forward PE | - | 17.42 | 17.42 | 17.42 | 17.42 | 17.42 | Upgrade
|
| PS Ratio | 2.41 | 2.46 | 2.30 | 2.36 | 1.80 | 3.63 | Upgrade
|
| PB Ratio | 1.26 | 1.28 | 1.37 | 1.64 | 1.78 | 3.41 | Upgrade
|
| P/TBV Ratio | 1.31 | 1.34 | 1.43 | 1.72 | 1.88 | 3.71 | Upgrade
|
| P/FCF Ratio | 49.36 | 50.34 | - | 12.59 | 17.13 | 26.02 | Upgrade
|
| P/OCF Ratio | 13.92 | 14.20 | 10.09 | 7.02 | 7.94 | 15.83 | Upgrade
|
| EV/Sales Ratio | 1.85 | 1.90 | 1.85 | 1.95 | 1.67 | 3.60 | Upgrade
|
| EV/EBITDA Ratio | 12.50 | 13.35 | 7.48 | 9.57 | 10.21 | 19.64 | Upgrade
|
| EV/EBIT Ratio | 46.29 | 47.67 | 13.37 | 15.89 | 17.55 | 33.92 | Upgrade
|
| EV/FCF Ratio | 37.79 | 38.92 | - | 10.39 | 15.88 | 25.80 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.03 | 0.13 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 0.26 | 0.26 | 0.19 | 0.23 | 0.77 | 1.11 | Upgrade
|
| Debt / FCF Ratio | 0.79 | 0.79 | - | 0.26 | 1.27 | 1.54 | Upgrade
|
| Net Debt / Equity Ratio | -0.29 | -0.29 | -0.28 | -0.32 | -0.22 | -0.12 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.94 | -3.94 | -1.90 | -2.27 | -1.36 | -0.69 | Upgrade
|
| Net Debt / FCF Ratio | -11.48 | -11.48 | 35.95 | -2.47 | -2.12 | -0.91 | Upgrade
|
| Asset Turnover | 0.42 | 0.42 | 0.48 | 0.53 | 0.69 | 0.66 | Upgrade
|
| Inventory Turnover | 3.76 | 3.76 | 3.57 | 4.45 | 7.23 | 5.79 | Upgrade
|
| Quick Ratio | 2.43 | 2.43 | 2.21 | 2.25 | 1.81 | 1.55 | Upgrade
|
| Current Ratio | 3.03 | 3.03 | 2.73 | 2.72 | 2.11 | 1.89 | Upgrade
|
| Return on Equity (ROE) | 2.09% | 2.09% | 9.31% | 9.93% | 8.36% | 9.33% | Upgrade
|
| Return on Assets (ROA) | 1.04% | 1.04% | 4.18% | 4.08% | 4.12% | 4.36% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.94% | 2.92% | 11.33% | 10.67% | 10.69% | 9.47% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.00% | 2.00% | 7.90% | 8.30% | 9.10% | 9.40% | Upgrade
|
| Earnings Yield | 1.70% | 1.67% | 6.43% | 5.77% | 4.43% | 2.20% | Upgrade
|
| FCF Yield | 2.03% | 1.99% | -0.57% | 7.94% | 5.84% | 3.84% | Upgrade
|
| Dividend Yield | 1.40% | - | 1.31% | 1.19% | 0.93% | 0.47% | Upgrade
|
| Payout Ratio | 82.27% | 82.27% | 20.34% | 19.44% | 25.54% | 50.92% | Upgrade
|
| Buyback Yield / Dilution | -2.58% | -2.58% | -0.56% | -0.30% | -2.10% | -8.59% | Upgrade
|
| Total Shareholder Return | -1.20% | -2.58% | 0.74% | 0.89% | -1.17% | -8.13% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.